Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 2 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
FDA Approves First Interchangeable Biosimilars to Aflibercept for AMD
MedPage Today· 4 days agoThe FDA approved the first interchangeable biosimilars to aflibercept (Eylea) to treat macular degeneration, according to an announcement ...
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $5.50 Average Price Target from Analysts
ETF DAILY NEWS· 7 hours agoShares of Kodiak Sciences Inc. (NASDAQ:KOD – Get Free Report) have received an average recommendation of “Reduce” from the seven analysts that are currently covering the company, Marketbeat.com ...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 3 days agoLtd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (US FDA) has approved the Company's first-to-file application for Yesafili™ (aflibercept-jbvf) ...
FDA approves 2 Eylea biosimilars
Becker’s Hospital Review· 4 days agoThe FDA granted approval to Biocon Biologics' drug Yesafili and Samsung Bioepis and Biogen's drug Opuviz, the agency announced May 20. The two drugs are biosimilars for Eylea, an injection made ...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 3 days agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
7 Biotech Stocks That Could Breathe New Life Into Your Portfolio
InvestorPlace· 4 days agoFundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...
Alvotech (ALVO) Scheduled to Post Quarterly Earnings on Tuesday
ETF DAILY NEWS· 5 days agoAlvotech (NYSE:ALVO – Get Free Report) will post its quarterly earnings results after the market closes on Tuesday, May 21st. Individual interested in participating in the company’s earnings ...
Foundation Fighting Blindness to Host VISIONS 2024 Conference
WFRV 5 Green Bay· 7 days agoThis biennial event offers a unique opportunity for attendees to connect with others from the blind and low vision community and learn about the latest research advancements, products, and services ...
'Hard work and fresh air' may be the secrets to a long life for 105-year-old Irene Jones
Gannett via AOL· 2 days agoShe appreciates when her opponents help out by announcing the card suit played. Theirs is a...